The following are the stocks scheduled for February, with regulatory catalysts.
1. Adamas Pharmaceuticals Inc. (ADMS)
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com